Avsola and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Avsola (infliximab-axxq), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Humira, and have Crohn's disease.

The phase IV clinical study analyzes which people have Dyspnea when taking Avsola. It is created by eHealthMe based on reports of 513 people who have side effects when taking Avsola from the FDA, and is updated regularly.

What is Avsola?

Avsola has active ingredients of infliximab-axxq. eHealthMe is studying from 514 Avsola users. Check the latest studies of Avsola.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,723 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

513 people reported to have side effects when taking Avsola.
Among them, 18 people (3.51%) have Dyspnea.

Among these 18 people:

How long have people been on Avsola when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Avsola? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Dyspnea when taking Avsola? *

What are other drugs people take besides Avsola? *

What are other side effects people have besides Dyspnea? *

Infusion Related Reaction: 5 people, 27.78%
Chest Pain: 4 people, 22.22%
Throat Tightness: 4 people, 22.22%
Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 16.67%
Oxygen Saturation Decreased: 3 people, 16.67%
Swallowing Difficulty: 2 people, 11.11%
Pain: 2 people, 11.11%
Itching: 2 people, 11.11%
Back Pain: 1 person, 5.56%
Blood Pressure Immeasurable: 1 person, 5.56%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 22.22%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 5.56%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.56%
Inflammatory Bowel Disease: 1 person, 5.56%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Avsola and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avsola:

Avsola (514 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

Browse all side effects of Avsola:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,723 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-axxq (the active ingredients of Avsola) and Avsola (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.